Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations

Go back to Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations
(NASDAQ: CODX) Delayed: 1.15 +0.06 (5.50%)
Previous Close $1.09    52 Week High $ 
Open $1.11    52 Week Low $ 
Day High $1.15    P/E N/A 
Day Low $1.09    EPS $ 
Volume 79,743